Anxiety treatment for Delray Beach — SSRI dosing done right, CBT that works.

RECO Integrated Psychiatry runs outpatient anxiety care out of a Delray Beach office off Atlantic Avenue — under ten minutes from Pineapple Grove, Lake Ida, and the Beach District. Care is specialist psychiatry: SSRIs titrated to the anxiety range (sertraline 150–200 mg, escitalopram 20 mg), buspirone or low-dose aripiprazole augmentation where indicated, and a defined referral pathway to CBT and ERP for panic disorder and OCD. Benzodiazepines are used narrowly, with a documented taper timeline, not as open-ended maintenance.

The RECO Integrated Psychiatry office sits a short walk from Atlantic Avenue, in the same downtown grid that runs through Pineapple Grove, Lake Ida, and the Beach District — neighborhoods where most of our anxiety patients already live and work. For Delray Beach residents, specialist psychiatric care does not require rearranging a life around a residential program or a commute to Boca Raton or West Palm. Weekly medication visits, outpatient anxiety treatment, TMS series, Spravato sessions, and telepsychiatry follow-ups all happen in the same walkable block already familiar to most local patients.

The disorder distinctions that change treatment

Generalized anxiety disorder, panic disorder, social anxiety disorder, and obsessive-compulsive disorder are routinely lumped together as “anxiety” in casual conversation and in many primary-care visits. They are not interchangeable. Each carries a distinct DSM-5-TR criterion set, a distinct evidence-based therapy protocol, and often a distinct medication dosing target. A referral for “anxiety” that never distinguishes GAD from panic from OCD is a referral that will underperform.

Intake at RECO Integrated Psychiatry uses structured scales rather than a global impression. The GAD-7 quantifies worry-based symptoms and monitors response. The PDSS captures panic frequency, anticipatory anxiety, and phobic avoidance. The LSAS measures social fear and avoidance across performance and interaction situations. The Y-BOCS tracks obsessions and compulsions separately and is sensitive enough to detect a partial SSRI response that a clinical impression would miss. The intake note names a DSM-5-TR primary diagnosis; it does not stop at “anxiety NOS.”

Comorbidity is the rule rather than the exception. A patient may meet criteria for GAD, panic disorder, and OCD simultaneously, often with a depressive episode overlaid. The treatment plan sequences the disorders by severity and functional impact — whichever condition is keeping the patient out of work, school, or relationships is addressed first, with the others tracked in parallel and treated in a defined order.

SSRI dosing for anxiety versus depression

Effective SSRI doses for anxiety disorders sit at the upper end of the depression range, and reaching those doses is the single most common failure point in outpatient anxiety treatment. Sertraline for GAD or OCD is typically titrated to 150–200 mg per day. Escitalopram for GAD or panic disorder is often 20 mg. Paroxetine for social anxiety disorder is 40–60 mg. A patient stalled at 50 mg of sertraline or 10 mg of escitalopram has not yet had an adequate trial.

The other end of the dosing curve matters just as much. Anxious patients are often activated on SSRI initiation — jittery, restless, insomnia, transiently worse anxiety — and that experience is the reason many patients discontinue the medication before it has had time to work. The default here is to start at half the usual starting dose (sertraline 25 mg, escitalopram 5 mg) for one to two weeks before advancing, with an honest conversation about the activation window and the expected six-to-eight-week response curve.

Response is measured against the intake scale, not against how the patient reports feeling on a given day. A reduction of 50% or more on the GAD-7 or Y-BOCS defines a meaningful response; anything less prompts a dose review before any switch or augmentation is considered.

Augmentation and second-line options

SSRI partial responders in GAD are augmented with buspirone at 20–60 mg per day divided TID. Buspirone is not sedating, has no dependence liability, and is a genuine option for patients who have plateaued on an adequate SSRI trial. For panic disorder partial responders, the evidence favors adding CBT with interoceptive exposure over adding a second medication — the reduction in panic frequency from a structured exposure protocol typically outpaces what a medication switch achieves.

OCD is different. Partial responders on a maxed-out SSRI benefit more from augmentation with low-dose aripiprazole (2–5 mg) or risperidone (0.5–2 mg) than from switching to an SNRI. The evidence for antipsychotic augmentation in OCD is stronger than for the switch, and the augmentation strategy runs alongside exposure and response prevention, which remains the definitive treatment. Coordination with ERP-trained therapists in Palm Beach County is arranged at referral.

Beta-blockers such as propranolol 10–40 mg have a defined role in situational performance anxiety and are dosed on demand before a specific trigger, not chronically. Gabapentin and hydroxyzine cover PRN anxiolytic needs without the dependence and cognitive risks of benzodiazepines, and either is a reasonable bridge for a patient who needs something for breakthrough symptoms during SSRI titration.

Benzodiazepines — when we do and don’t prescribe

Benzodiazepines have a legitimate role in short-term crisis management and in a narrow set of chronic indications, most commonly panic disorder that has failed adequate trials of two SSRIs and a course of CBT. Outside those situations, the case for chronic benzodiazepine prescribing is weak and the case against is strong: they blunt exposure-based CBT extinction learning, they carry documented dependence and cognitive risks, and they complicate treatment for any co-occurring alcohol or opioid use disorder.

For patients with any personal or family history of substance use disorder, the default is not to prescribe. Anxiety in that population is treated with the SSRI or SNRI ladder, buspirone, hydroxyzine, gabapentin, propranolol, and CBT referral — the same tools that work for everyone else, without introducing a controlled substance that will not survive the recovery plan.

When benzodiazepines are prescribed, the treatment plan documents the indication, the expected duration, a taper timeline, and the non-benzodiazepine alternatives that will replace them. Open-ended maintenance is not the standard of care and is not the standard here.

What to expect on the first visit

The initial evaluation runs 60–90 minutes with a psychiatrist or psychiatric nurse practitioner. Patients complete the GAD-7, PHQ-9, and disorder-specific scales in advance so the visit is spent on history, differential diagnosis, and a written treatment plan rather than paperwork. Medication history, prior therapy history, medical comorbidities, and family psychiatric history are all covered in the intake.

Patients leave the first visit with a named primary diagnosis, a specific medication plan including target doses and titration schedule, a therapy referral to a CBT or ERP clinician when indicated, and a follow-up appointment inside two to four weeks. Ongoing medication management visits are typically 25–30 minutes, monthly during titration and quarterly once stable on an effective regimen.

Insurance and admissions from Delray Beach

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. Verification of benefits is completed before the first visit so out-of-pocket cost is known in advance; prior-authorization requirements for TMS and Spravato are handled by the clinical team.

Because the office is in Delray Beach itself, drive time from Pineapple Grove, Lake Ida, Tropic Isle, the Beach District, and Osceola Park is under ten minutes. Telepsychiatry follow-ups are available for medication management under Florida telehealth rules; TMS and Spravato appointments require in-person attendance.

Serving residents of: Pineapple Grove, Lake Ida, Tropic Isle, Beach District, Osceola Park.